Freedman B, Weijer C, Cranley Glass K. Placebo orthodoxy in clinical research II: ethical, legal, and regulatory myths. Journal of Law, Medicine & Ethics 1996b; 24: 252-259.
Freedman B, Weijer C, Cranley Glass K. Placebo orthodoxy in clinical research I: empirical and methodological myths.
Journal of Law, Medicine & Ethics 1996a; 24: 243-251.
Elliott C, Weijer C. Cruel and unusual treatment. Saturday Night 1995; December: 31-34.
Beauchamp TL, Childress, JF. Principles of biomedical ethics. 4th Ed. New York: Oxford University Press; 1994.
48th World Medical Association General Assembly. Declaration of Helsinki, 5th revision. Somerset West, South
Africa; 1996
Malette vs. Shulman (Ont. C.A.)72 O.R.(2d) 417, [1990] O.J. No.450.
Malone RP, Simpson GM. Use of placebos in clinical trials involving children and adolescents. Psychiatric Services 1998;
: 1413-1414.
Ney PG, Collins C, Spensor C. Double blind: double talk or are there ways better to do better research? Medical Hypotheses 1986; 21: 119-126.
Molcho A, Stanley M. Antidepressants and suicide risk: issues of chemical and behavioral toxicity. Journal of Clinical
Psychopharmacology 1992; 12 (suppl.): 13S-18S.
Addington D, Williams R, Lapierre Y, el-Giebaly N. Placebos in clinical trials of psychotropic medication. Canadian Journal of Psychiatry 1997; 42: 6pp insert.
Kane JM. Tardive dyskinesia: epidemiological and clinical presentation. In: Bloom F, Kupfer DJ, eds.
Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995: 1485-1495.
Fisher RL, Fisher S. Antidepressants for children: is scientific support necessary? Journal of Nervous and Mental Disease
; 184: 99-102.
Burack JH, Back AL, Pearlman RA. Provoking nonepileptic seizures: the ethics of deceptive diagnostic testing. Hastings
Center Report 1997; 27: 24-33.
Appelbaum PS. Rethinking the conduct of psychiatric research. Archives of General Psychiatry 1997; 54: 117-120.